Fundz

Biograil

Copenhagen, Capital Region of Denmark, Denmark · Biotechnology, Health Care, Pharmaceutical

Biograil is a Copenhagen-based BioTech company founded in 2019, focused on developing an oral device for delivering therapeutics that would otherwise require injection. They leverage proprietary BIONDD technology to create oral capsules that dissolve in the stomach and facilitate drug delivery into the tissue. The company aims to transform the market for injectable pharmaceutical products into con

Key facts

Headquarters
Copenhagen, Capital Region of Denmark, Denmark
Employees
31
Industries
Biotechnology, Health Care, Pharmaceutical
Status
Private
Website
biograil.com
LinkedIn
Company page

Recent activity at Biograil

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Biograil funding history

DateRoundAmount
Nov 2026Venture$22.4M

Leadership

  • Karsten, Founder & CEO
  • Lene, Director Regulatory Affairs

Verified email and direct lines for Biograil’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Companies similar to Biograil

About Biograil: questions and answers

What does Biograil do?

Biograil is a Copenhagen-based BioTech company founded in 2019, focused on developing an oral device for delivering therapeutics that would otherwise require injection. They leverage proprietary BIONDD technology to create oral capsules that dissolve in the stomach and facilitate drug delivery into the tissue. The company aims to transform the market for injectable pharmaceutical products into con

Where is Biograil headquartered?

Biograil is headquartered in Copenhagen, Capital Region of Denmark, Denmark.

How many employees does Biograil have?

Biograil has about 31 employees.

Has Biograil raised funding?

Yes. Fundz has recorded 1 funding event for Biograil. The most recent, $22.4M, was in Nov 2026.

Who leads Biograil?

Karsten is a Founder & CEO at Biograil.

What is the latest news on Biograil?

On Nov 4, 2026, Copenhagen-based Biograil raises €20 million in a funding round for its innovative oral drug delivery device, with support from Verve Ventures and Megatrend Invest.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Biograil across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.